Table 2. Plate counts for different microbial groups expressed in logCFU/g.
T0 | T1 | T2 | T3 | T4 | |
---|---|---|---|---|---|
Enterococcus spp. | |||||
C | 5.67±0.03a | 5.08±0.04c | 5.76±0.01a | 5.30±0.04b | 5.83±0.16a |
CL | 6.34±0.06a | 4.66±0.08e | 5.98±0.08b | 5.18±0.10d | 5.56±0.04c |
CLF | 6.04±0.01b | 6.06±0.06b | 6.40±0.11a | 5.72±0.11c | 5.59±0.10c |
CLP | 5.56±0.04a | 4.13±0.00c | 4.80±0.45b | 5.81±0.04a | 6.04±0.02a |
CLS | 5.90±0.01ab | 6.03±0.06a | 5.81±0.09b | 4.73±0.02c | 5.85±0.06b |
Lactobacillus spp. | |||||
C | 6.83±0.08a | 6.09±0.09c | 6.43±0.05b | 5.78±0.02d | 6.45±0.02b |
CL | 6.65±0.00a | 6.47±0.05b | 6.76±0.01a | 5.95±0.08c | 6.41±0.01b |
CLF | 6.04±0.01d | 5.86±0.04e | 6.62±0.01b | 6.52±0.01c | 6.88±0.02a |
CLP | 6.45±0.05bc | 5.79±0.05d | 6.56±0.07b | 6.42±0.02c | 6.86±0.04a |
CLS | 6.47±0.02b | 6.03±0.06c | 6.80±0.08a | 6.45±0.02b | 6.81±0.10a |
Bifidobacterium spp. | |||||
C | 7.02±0.00a | 6.58±0.05b | 6.36±0.10c | 6.34±0.08c | 5.99±0.02d |
CL | 6.92±0.01a | 5.96±0.05c | 6.52±0.02b | 5.92±0.01c | 5.75±0.09d |
CLF | 5.11±0.01c | 6.00±0.20b | 6.53±0.08a | 6.40±0.03a | 6.46±0.05a |
CLP | 5.90±0.01c | 5.37±0.07d | 5.92±0.04c | 6.39±0.04a | 6.17±0.10b |
CLS | 6.78±0.01a | 6.01±0.11b | 5.39±0.06d | 5.70±0.02c | 5.85±0.06bc |
Clostridium spp. | |||||
C | 6.86±0.03a | 6.41±0.10b | 6.37±0.16b | 6.56±0.07b | 6.10±0.07c |
CL | 6.78±0.02a | 5.72±0.02d | 6.82±0.04a | 5.99±0.02c | 6.41±0.08b |
CLF | 6.45±0.08a | 5.80±0.04b | 6.48±0.07a | 6.39±0.06a | 6.55±0.07a |
CLP | 6.40±0.17b | 5.81±0.06c | 6.71±0.09a | 6.48±0.04ab | 6.65±0.03a |
CLS | 6.63±0.04ab | 6.72±0.03a | 6.45±0.05b | 6.52±0.06b | 6.59±0.11ab |
Enterobacteria | |||||
C | 3.17±0.06ab | 2.76±0.03c | 3.43±0.10a | 3.05±0.04bc | 2.91±0.19bc |
CL | 3.63±0.11a | 3.14±0.03bc | 3.24±0.06b | 2.99±0.03c | 3.27±0.03b |
CLF | 3.01±0.00ba | 2.34±0.31c | 3.26±0.03a | 2.85±0.06b | 2.82±0.08b |
CLP | 2.48±0.13d | 2.65±0.08cd | 3.27±0.15a | 2.93±0.04b | 2.77±0.01bc |
CLS | 2.85±0.02b | 3.06±0.06a | 2.77±0.14bc | 2.66±0.00c | 2.65±0.02c |
Bacteroides spp. | |||||
C | 3.02±0.02b | 3.70±0.01a | 2.41±0.08c | 3.02±0.10b | 3.01±0.09b |
CL | 3.03±0.03b | 3.65±0.06a | 2.48±0.03c | 3.08±0.01b | 3.18±0.02b |
CLF | 2.77±0.01a | 2.53±0.08a | 2.65±0.08a | 2.70±0.10a | 2.59±0.02a |
CLP | 2.77±0.07a | 2.74±0.12a | 2.46±0.05b | 2.60±0.02a | 2.69±0.06a |
CLS | 3.77±0.13a | 2.58±0.13b | 2.56±0.22b | 2.48±0.01b | 2.73±0.02b |
Means ±SD with the same letter in the same row are not statistically different from each other (p<0.05). Group C: negative control–healthy animals; Group CL: positive control—DSS; Group CLF: DSS with the fermented product; Group CLP: DSS with the non-fermented product (placebo); Group CLS: DSS with sulfasalazine. T0 = before products administration, T1 = one week after products administration, T2 = colitis induction period, T3 = one week after the end of the induction T4 = at the end of the experiment. n = 10.